However, the story reports mainly from news releases, misses some important study limitations, and doesn’t include independent voices.
When it comes to an up-and-coming procedure like this, it’s buyer beware.
The story does well in giving some background regarding stem cells, and highlighting how this is a growing trend with not a lot of evidence.
The story did a good job describing the study, the potential harms of the intervention, and limitations to the findings.
This story provided lots of important details, but not quite enough to help a person answer: Is the treatment–when done in both eyes–worth nearly a million dollars?
But the story had several independent sources, and did a good job describing the study’s design.
Nor does it answer: Does exercise help a little? A lot?
The story would have been stronger if it had included some commentary from experts in the field who were not associated with the study, though.
When it comes to the ADHD drug Vyvanse helping smokers quit, this article is much ado about nothing.
But, the story did a good job discussing costs and laying out the study design for readers.